(from old pr):"combination studies with multikinase inhibitors ( plura l), under development from a large pharmaceutical manufacturer, which activate pro-apoptotic activity by translocation of p53 in mitochondria and inducing apoptosis. This study will provide vital insight to exploit the nuclear and/or mitochondrial pro-apoptotic function by Kevetrin in combination with other multikinase inhibitors (plural ) in treatment of these malignancies."
OK - So, given content of this pr - we beleive this is first of more than one combo test to show positive results? ANd more to come. Or...it could be first to show positive results with a few nonpositives behind it? Anyone?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links